openPR Logo
Press release

GenoFAB Joins BioMADE to Accelerate Industrial Biomanufacturing Through Advanced Genetic Design Expertise

04-16-2025 05:02 PM CET | Health & Medicine

Press release from: Getnews

/ PR Agency: Brand Push
GenoFAB Joins BioMADE to Accelerate Industrial

Colorado State University startup GenoFAB has joined BioMADE, connecting with over 300 organizations nationwide to advance biomanufacturing innovation. GenoFAB contributes critical expertise in genetic design and plasmid management, helping engineer microorganisms that transform raw materials into sustainable products. This partnership strengthens America's bioindustrial manufacturing capabilities while accelerating research and product development in the bioeconomy.
Image: https://www.globalnewslines.com/uploads/2025/04/c446c077297e9ab30d36c42f32bd9d44.jpg

Fort Collins, CO - GenoFAB [https://genofab.com/], a Colorado State University startup [https://csustrata.org/technology-transfer/startups/meet-our-startups/], has joined BioMADE, a non-profit public-private partnership dedicated to securing America's future through bioindustrial manufacturing innovation, education, and collaboration. This strategic membership connects GenoFAB with BioMADE's nationwide network [https://www.biomade.org/biomade-members] of over 300 member organizations working collectively to solve critical biomanufacturing challenges. By joining this Manufacturing Innovation Institute (MII), GenoFAB becomes part of a diverse consortium committed to developing sustainable, bio-based products and manufacturing processes.

"BioMADE unites leaders across industry, government, and academia to build the foundation for a thriving domestic bioindustrial manufacturing sector," said Jean Peccoud, Founder of GenoFAB. "We are excited to collaborate with fellow members to help shape the future of biomanufacturing and contribute our genetic design capabilities to this important national initiative."

The development of effective biomanufacturing processes hinges on precisely engineering the microorganisms that transform raw feedstocks into valuable final products. GenoFAB's expertise in this critical area represents a significant contribution to BioMADE's mission. By applying advanced genetic design tools and methodologies, GenoFAB enables the creation and optimization of microbial cell factories that can efficiently convert renewable resources into sustainable chemicals, materials, and fuels.

"The ability to rapidly engineer microorganisms with specific metabolic capabilities is a cornerstone of industrial biomanufacturing," explained Jean Peccoud. "Our plasmid design [https://genofab.com/products/design] and management [https://genofab.com/collections/services] solutions help streamline this process, reducing development timelines and improving reproducibility across the biomanufacturing pipeline."

This partnership strengthens GenoFAB's commitment to advancing the bioeconomy through more efficient genetic design and data-driven product development strategies that support scalable biomanufacturing solutions. GenoFAB's specialized capabilities in genetic design and plasmid construction directly align with BioMADE's goal of transforming manufacturing processes for everyday products through biological innovation.

As the biomanufacturing industry continues to evolve, the need for standardized genetic tools and robust design frameworks becomes increasingly critical. GenoFAB's systematic approach to developing and managing genetic resources addresses these needs, offering BioMADE members access to technologies that can accelerate the transition from laboratory concept to commercial-scale production.

GenoFAB's participation in BioMADE underscores its dedication to driving innovation, developing industry standards, and supporting life scientists working at the critical intersection of research and commercial applications.

About GenoFAB

GenoFAB empowers life scientists and biotechnology companies to accelerate research and product development by delivering precisely engineered plasmids when they're needed most. The company eliminates the risks associated with poor plasmid management-including unexpected delays, cost overruns, quality control issues, and commercialization roadblocks-allowing scientists to focus on discovery and companies to concentrate on their core business objectives. GenoFAB provides comprehensive plasmid management services spanning the entire lifecycle, from initial design through distribution and commercialization.
Media Contact
Company Name: GenoFAB, Inc
Contact Person: Jean Peccoud
Email: Send Email [http://www.universalpressrelease.com/?pr=genofab-joins-biomade-to-accelerate-industrial-biomanufacturing-through-advanced-genetic-design-expertise]
Country: United States
Website: https://genofab.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release GenoFAB Joins BioMADE to Accelerate Industrial Biomanufacturing Through Advanced Genetic Design Expertise here

News-ID: 3974493 • Views:

More Releases from Getnews

How to Know When Vertigo Requires Specialized Care: Chiropractor in Boulder Offers Guidance
02-03-2026 | Health & Medicine
Getnews
How to Know When Vertigo Requires Specialized Care: Chiropractor in Boulder Offe …
Image: https://www.globalnewslines.com/uploads/2026/01/1769669987.jpg "Vertigo that comes and goes or flares with movement is often a sign that the upper spine needs to be checked," said the company spokesperson. "We see people who've been given exercises, pills, or nothing at all. When we correct pressure at the brainstem, the body starts to regulate balance again." Atlas Chiropractic in Boulder helps people with vertigo that does not respond to common treatments. The clinic focuses on
Y-Warm to Showcase Next-Generation Thermal Material at the 27th Jinjiang Footwear International Expo
Y-Warm to Showcase Next-Generation Thermal Material at the 27th Jinjiang Footwea …
JINJIANG, China - The 27th Jinjiang Footwear & the 10th Sports Industry International Expo, one of the world's leading trade events for footwear and sports innovation, will be held from April 19 to 22, 2026, at the Jinjiang International Convention and Exhibition Center, organizers announced. The four-day event is expected to span more than 60,000 square meters and attract over 150,000 professional visitors from China and abroad. The expo will feature
The Winslow Announces Full 2026 Guinness Six Nations Rugby Coverage
The Winslow Announces Full 2026 Guinness Six Nations Rugby Coverage
Image: https://www.getnews.info/uploads/1713864312.jpeg East Village Bar to Show All 15 Matches Live, Opening 30 Minutes Before Kickoff The Winslow, located at 243 East 14th Street in New York City's East Village, will broadcast all 15 matches of the 2026 Guinness Six Nations Championship live throughout February and March. NEW YORK, NY - February 3, 2026 - The Winslow, located at 243 East 14th Street in New York City's East Village, will broadcast all 15
Christopher Care Center Announces Drug Rehab Services Supporting Recovery in Mission Viejo, California
Christopher Care Center Announces Drug Rehab Services Supporting Recovery in Mis …
Christopher Care Center Introduces Evidence-Based Drug Rehab Programs for Individuals Seeking Treatment in Mission Viejo Christopher Care Center continues to serve individuals and families seeking structured and clinically guided support for substance use recovery in Southern California. Located in Mission Viejo, the center focuses on providing treatment programs designed to address substance dependence through established therapeutic methods and individualized care planning. Image: https://www.globalnewslines.com/uploads/2026/01/12852ed6b415b18ef6b1ce3e8320d879.jpg Substance use disorders remain a significant public health concern across

All 5 Releases


More Releases for GenoFAB

Asia-Pacific Bioinformatics Market to Reach at a CAGR 21.4% to 2030 | Major Play …
DataM Intelligence has published a new research report on "Asia-Pacific Bioinformatics Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. Get a Sample PDF Of This Report (Get
Bio-Based Molecule Market Driven by Sustainability Goals and Rising Demand for B …
"The Global Bio-based Molecule Market reached US$1,336.72 million in 2023 and is expected to reach US$2,437.83 million by 2031, growing with a CAGR of 7.8% during the forecast period 2024-2031," according to DataM Intelligence. The Bio-Based Molecule Market is spearheaded by leading industrial biotech firms, including Arkema, Covestro, and Borregaard, backed by global engineering groups like GEA Group and DE Smet Engineers. AVA Biochem, Jiangmen Xinshuo, and NTIC excel in fine
GenoFAB Launches Hybrid Plasmid Sequencing Service To Set a New Standard for Rep …
New service enhances plasmid quality control for research and manufacturing. Image: https://www.globalnewslines.com/uploads/2025/02/fe7ca2654c3c0350e277e71d3a85afcc.jpg GenoFAB is introducing a whole plasmid sequencing service, a groundbreaking solution designed to enhance reproducibility and quality control in biotechnology research and biomanufacturing. By leveraging both long-read and short-read sequencing technologies, GenoFAB ensures unprecedented base-level accuracy, addressing a critical challenge in the field. Plasmids are the foundation of many biopharmaceutical, synthetic biology, and gene therapy applications, yet plasmid quality control remains
North America Bioinformatics Market Will Accelerate Rapidly with Promising CAGR …
The North America Bioinformatics market is estimated to grow at a high CAGR from 2024 to 2031. The North America North America Bioinformatics Market report is the most important research for who looks for all information about the market. The report covers all information about the regional markets, including historical and future trends for market dominance, size, trades, supply, competitors, and prices, as well as key vendor information across the region.
NA Bioinformatics Market Size, Share, Industry, Forecast to 2029
The NA Bioinformatics Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global NA Bioinformatics market. This report explores all the key factors affecting the growth of the global NA Bioinformatics market, including
APAC Bioinformatics Market Size, Share, Industry, Forecast to 2029
The APAC Bioinformatics Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global APAC Bioinformatics market. This report explores all the key factors affecting the growth of the global APAC Bioinformatics market, including